133 related articles for article (PubMed ID: 3511867)
21. The pathogenesis, detection, and surgical treatment of hepatic metastases.
Hanks JB; Jones RS
Curr Probl Cancer; 1986 May; 10(5):217-65. PubMed ID: 2872997
[No Abstract] [Full Text] [Related]
22. Liver function tests in metastatic uveal melanoma.
Kaiserman I; Amer R; Pe'er J
Am J Ophthalmol; 2004 Feb; 137(2):236-43. PubMed ID: 14962411
[TBL] [Abstract][Full Text] [Related]
23. Preoperative ultrasonography screening for liver metastases of patients with colorectal cancer.
Yoshida T; Matsue H; Suzuki M; Okazaki N; Yoshino M; Moriya Y; Hojo K
Jpn J Clin Oncol; 1989 Jun; 19(2):112-5. PubMed ID: 2659845
[TBL] [Abstract][Full Text] [Related]
24. Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients.
Fahmueller YN; Nagel D; Hoffmann RT; Tatsch K; Jakobs T; Stieber P; Holdenrieder S
Int J Cancer; 2013 May; 132(10):2349-58. PubMed ID: 23047645
[TBL] [Abstract][Full Text] [Related]
25. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study.
Ruers TJ; Langenhoff BS; Neeleman N; Jager GJ; Strijk S; Wobbes T; Corstens FH; Oyen WJ
J Clin Oncol; 2002 Jan; 20(2):388-95. PubMed ID: 11786565
[TBL] [Abstract][Full Text] [Related]
26. Trends in nontherapeutic laparotomy rates in patients undergoing surgical therapy for hepatic colorectal metastases.
Pawlik TM; Assumpcao L; Vossen JA; Buijs M; Gleisner AL; Schulick RD; Choti MA
Ann Surg Oncol; 2009 Feb; 16(2):371-8. PubMed ID: 19020939
[TBL] [Abstract][Full Text] [Related]
27. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
Wong CY; Salem R; Raman S; Gates VL; Dworkin HJ
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):815-20. PubMed ID: 12029557
[TBL] [Abstract][Full Text] [Related]
28. Perioperative carcinoembryonic antigen measurements to predict curability after liver resection for colorectal metastases: a prospective study.
Oussoultzoglou E; Rosso E; Fuchshuber P; Stefanescu V; Diop B; Giraudo G; Pessaux P; Bachellier P; Jaeck D
Arch Surg; 2008 Dec; 143(12):1150-8; discussion 1158-9. PubMed ID: 19075165
[TBL] [Abstract][Full Text] [Related]
29. Prospective comparative study of ultrasound, CT-scan, scintigraphy and laboratory tests to detect hepatic metastases.
de Brauw LM; van de Velde CJ; Pauwels EK; Bok R; Bloem JL; Aarts JC; Hermans J
J Nucl Biol Med (1991); 1991; 35(3):131-4. PubMed ID: 1816868
[TBL] [Abstract][Full Text] [Related]
30. PET-CT as a predictor of outcome in resectable colorectal liver metastases.
Jones C; Badger SA; Stevenson M; Diamond T; McKie LD; Taylor MA; Wilson RH; Lynch TB
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):466-72. PubMed ID: 24445726
[TBL] [Abstract][Full Text] [Related]
31. Liver function tests in patients with computed tomography demonstrated hepatic metastases.
Ottmar MD; Gonda RL; Leithauser KJ; Gutierrez OH
Gastrointest Radiol; 1989; 14(1):55-8. PubMed ID: 2910745
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of peroperative liver function tests and ultrasound in detecting hepatic metastasis in carcinoma of the breast.
Clark CP; Foreman ML; Peters GN; Cheek JH; Sparkman RS
Surg Gynecol Obstet; 1988 Dec; 167(6):510-4. PubMed ID: 3055370
[TBL] [Abstract][Full Text] [Related]
33. The role of CEA and liver function tests in the detection of hepatic metastases from colo-rectal cancer.
Bonfanti G; Bombelli L; Bozzetti F; Doci R; Gennari L; Koukouras D
HPB Surg; 1990; 3(1):29-36; discussion 36-7. PubMed ID: 2090187
[TBL] [Abstract][Full Text] [Related]
34. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis.
Hohenberger P; Schlag PM; Gerneth T; Herfarth C
Ann Surg; 1994 Feb; 219(2):135-43. PubMed ID: 8129484
[TBL] [Abstract][Full Text] [Related]
35. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
Wiering B; Krabbe PF; Jager GJ; Oyen WJ; Ruers TJ
Cancer; 2005 Dec; 104(12):2658-70. PubMed ID: 16315241
[TBL] [Abstract][Full Text] [Related]
36. Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure.
Didolkar MS; Fitzpatrick JL; Elias EG; Whitley N; Keramati B; Suter CM; Brown S
Surg Gynecol Obstet; 1989 Jul; 169(1):17-26. PubMed ID: 2740965
[TBL] [Abstract][Full Text] [Related]
37. Preoperative assessment of the patient with breast cancer.
Baker RR
Surg Clin North Am; 1978 Aug; 58(4):681-91. PubMed ID: 356293
[TBL] [Abstract][Full Text] [Related]
38. Can biliary carcinoembryonic antigen identify colorectal cancer patients with occult hepatic metastases?
Li Destri G; Lanteri R; Santangelo M; Torrisi B; Di Cataldo A; Puleo S
World J Surg; 2006 Aug; 30(8):1494-9. PubMed ID: 16847713
[TBL] [Abstract][Full Text] [Related]
39. Neither preoperative computed tomography nor intra-operative examination can predict metastatic lymph node in the hepatic pedicle in patients with colorectal liver metastasis.
Rau C; Blanc B; Ronot M; Dokmak S; Aussilhou B; Faivre S; Vilgrain V; Paradis V; Belghiti J
Ann Surg Oncol; 2012 Jan; 19(1):163-8. PubMed ID: 21837526
[TBL] [Abstract][Full Text] [Related]
40. A matrix for controlled clinical trials for the study of hepatic metastases: proceedings of a workshop.
Sugarbaker PH; van de Velde CJ; Veenhof CH
J Surg Oncol; 1986 Feb; 31(2):94-9. PubMed ID: 3520148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
